Henriques, S.C.; Leblanc, A.; Simões, S.; Fonseca, M.; Pimentel, F.L.; Almeida, L.; Silva, N.E.
Unveiling the Potential of Cmax f2 Factor Applied to Pilot Bioavailability/Bioequivalence Studies—A Case Study with Pazopanib Drug Products. Pharmaceutics 2024, 16, 1579.
https://doi.org/10.3390/pharmaceutics16121579
AMA Style
Henriques SC, Leblanc A, Simões S, Fonseca M, Pimentel FL, Almeida L, Silva NE.
Unveiling the Potential of Cmax f2 Factor Applied to Pilot Bioavailability/Bioequivalence Studies—A Case Study with Pazopanib Drug Products. Pharmaceutics. 2024; 16(12):1579.
https://doi.org/10.3390/pharmaceutics16121579
Chicago/Turabian Style
Henriques, Sara Carolina, Ana Leblanc, Sérgio Simões, Marlene Fonseca, Francisco LuÃs Pimentel, Luis Almeida, and Nuno Elvas Silva.
2024. "Unveiling the Potential of Cmax f2 Factor Applied to Pilot Bioavailability/Bioequivalence Studies—A Case Study with Pazopanib Drug Products" Pharmaceutics 16, no. 12: 1579.
https://doi.org/10.3390/pharmaceutics16121579
APA Style
Henriques, S. C., Leblanc, A., Simões, S., Fonseca, M., Pimentel, F. L., Almeida, L., & Silva, N. E.
(2024). Unveiling the Potential of Cmax f2 Factor Applied to Pilot Bioavailability/Bioequivalence Studies—A Case Study with Pazopanib Drug Products. Pharmaceutics, 16(12), 1579.
https://doi.org/10.3390/pharmaceutics16121579
